Hot penny stocks... don't get burned
   

News for Marshall Edwards, Inc (MSHL)

Markets Quote Depth/LII Options Charts News Profile Financials Insiders Filings Analyst Earnings Historical
Symbol: powered by
  quotemedia.com
News for Marshall Edwards Inc.  (MSHL) 
|
$ 2.28    0.00 (0.00%) Volume: 0 4:00 PM EDT Sep 4, 2008
Mon, Aug 11, 2008
8:15 AM Marshall Edwards, Inc. to Present at the Canaccord Adams 28th Annual Global Growth Conference - Marketwire
Wed, Jul 30, 2008
8:22 AM Novogen Raises A$5.5m for Investment in Marshall Edwards - Marketwire
8:20 AM Marshall Edwards, Inc. Raises $10,000,000 in Public Offering - Marketwire
Thu, Jun 26, 2008
8:10 AM Marshall Edwards, Inc. Joins Russell 3000(R) Index - Marketwire
Mon, Jun 23, 2008
8:00 AM Novogen Signs Spanish Patent License With Laboratorios Casen-Fleet - Marketwire
Mon, Jun 09, 2008
8:00 AM Independent Data Monitoring Committee Recommends Marshall Edwards, Inc.'s OVATURE Trial Continue - Marketwire
Thu, May 15, 2008
9:00 PM Clinical Phase I Study Report of Marshall Edwards' Compound Triphendiol to Be Reported in ASCO Proceedings - Marketwire
Fri, May 09, 2008
8:29 AM Extended Accrual Time and Decreased Sample Size for OVATURE, a Multinational Phase III Clinical Study for Women With Recurrent Ovarian Cancer - Marketwire
Sun, Apr 13, 2008
4:00 PM Marshall Edwards, Inc.'s Investigational Drug Triphendiol (NV-196) Demonstrates Potent Activity Against Biliary Cancers - Marketwire
Tue, Mar 25, 2008
8:02 AM Data to Be Presented at AACR Reveals That the Marshall Edwards' Compound Triphendiol May Aid in Treatment of Pancreatic Cancer - Marketwire
Mon, Mar 10, 2008
8:01 AM Phenoxodiol Trials Highlighted at Ovarian Cancer Action International Conference - Marketwire
Tue, Feb 19, 2008
7:31 AM Additional Orphan Drug Status Granted for Melanoma for Marshall Edwards' Investigational Anti-Cancer Drug Triphendiol (NV-196) - Marketwire
Tue, Jan 22, 2008
8:54 AM Orphan Drug Status Granted for Marshall Edwards' Investigational Anti-Cancer Drug Triphendiol (NV-196) - Marketwire
Wed, Jan 09, 2008
10:25 AM Marshall Edwards, Inc. to Present at the 26th Annual JPMorgan Healthcare Conference - Marketwire
Mon, Oct 29, 2007
9:58 AM European Symposium Focuses on Phenoxodiol as an Investigational Drug for Ovarian Cancer Management - Marketwire
Wed, Oct 24, 2007
8:07 AM Novogen NV-128 Induces Novel Mode of Cell Death in Cancer Cells - Marketwire
Tue, Oct 23, 2007
8:05 AM New Data on Novogen Oncology Pipeline to Be Released - Marketwire
Mon, Oct 22, 2007
7:25 PM Yale Cancer Center Sponsors Study of Phenoxodiol for Prostate Cancer - Marketwire
7:04 PM European Symposium on Phenoxodiol as an Investigational Drug for Ovarian Cancer Management - Marketwire
Wed, Oct 03, 2007
9:40 AM Marshall Edwards, Inc. to Present at BIO Investor Forum 2007 - PR Newswire
Thu, Aug 30, 2007
8:30 AM A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol - PR Newswire
Mon, Aug 27, 2007
9:29 AM First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial - PR Newswire
9:22 AM First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial - PR Newswire
Mon, Aug 13, 2007
9:41 AM Newly Published Research Indicates the Potential of Phenoxodiol to Protect Against Neuropathy - PR Newswire
Tue, Aug 07, 2007
8:00 AM Marshall Edwards, Inc. Raises US$16.4 Million in Private Equity Financing - PR Newswire
  Page 1 of 3   Next Page

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.   RT   Realtime,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia.  Terms of Use. 
   
Research Report
Hotstocked.com has a complete research report available for MSHL stock. Download MSHL report.
Research Report
Get the full report for FREE
Date:Sep 3, 2008
Price:Free
Pages:4
Document Type:Adobe Acrobat Reader
 Download MSHL report
  
Example preview: Research report for Marshall Edwards, Inc (MSHL) Research report for Marshall Edwards, Inc (MSHL) Research report for Marshall Edwards, Inc (MSHL) Research report for Marshall Edwards, Inc (MSHL)
   
   
   
Attention: Please help us to improve our services by answering the following poll:



Please Leave a comment to tell us how you think we can improve our services.

Your message:
   
   
   
   
Summary
Research Report
Description
Level 2 quotes
Charts
News
Profile
Balance Sheet
Income Statement
Cash Flow Statement
Insiders
SEC Filings
Analyst Recommendation
Earnings Report
Historical Prices
Recent Material Events
Key executives
Comments
   
   
   
   

SPKL shot up 24%


From: OTC Journal
Added: 22 Sep, 2007

   

Add to Google
Add to My Yahoo!
rss
 
 
Home > Companies > Marshall Edwards, Inc
Home | Message boards | Newsletters | Latest Comments | VC directory | AIM London Stock Exchange | Canadian stocks | Chinese stocks | Broker Directory
About us | Privacy Policy | Disclaimer | Compensation Disclosure | Contributors | Contact form
© 2007 - 2008 hotstocked.com - All rights reserved.